AML Mutation Analysis Only : 1016109

Test Code
MDFCPAMLSEQ or 1016109

Alias/See Also
Acute Myeloid Leukemia; AML; Acute Promyelocytic Leukemia; APL; AML-M3; ASXL1; c-kit; DNMT3A; ETV6 (TEL); FLT3; IDH1; IDH2; KRAS; NPM1; NRAS; PHF6; PTEN; RUNX1; SF3B1; SRSF2; TET2; TP53; U2AF1; WT1; CEBPA; FLT3-ITD-TKD


CPT Codes
81450

Includes
Includes: ASXL1, CEBPA, DNMT3A, ETV6 (TEL), FLT3, FLT3-ITD, IDH1, IDH2, KIT, KRAS, NPM1, NRAS, PHF6, PTEN, RUNX1, SF3B1, SRSF2, TET2, TP53, U2AF1, WT1

Instructions
Peripheral Blood or Bone Marrow in a lavender top (EDTA) tube.

Transport Container
Submit 5-10 mL Blood or 2-3 mL Bone Marrow. Do not centrifuge.

Transport Temperature
Refrigerated.

Specimen Stability
Ambient: 48 hours; Refrigerated: 15 days; Frozen: Unacceptable

Methodology
Next Generation Sequencing and Sanger Sequencing (for CEBPA only)

Setup Schedule
Monday & Thursday

Report Available
8-10 days

Reference Range
An integrated report with results from all tests along with relevant diagnostic, prognostic and clinical trial information.

Clinical Significance
Helps physicians diagnose and predict the course of disease progression for hematologic diseases.

Performing Laboratory
med fusion; FLT3 LabPMM; CEBPA Quest SJC



The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.